{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:22:44Z","timestamp":1794428564360,"version":"4.9.1"},"reference-count":105,"publisher":"Informa UK Limited","issue":"15","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.1080\/1750743x.2025.2582464","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:11:53Z","timestamp":1762254713000},"page":"1115-1127","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Chimeric antigen receptor natural killer (CAR-NK) cells: from preclinical promise to clinical reality in cancer immunotherapy"],"prefix":"10.1080","volume":"17","author":[{"given":"Hunter Cassidy","family":"Cochran","sequence":"first","affiliation":[{"name":"Washington University School of Medicine, Center for Gene and Cellular Immunotherapy (CGCI)","place":["St Louis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Ashkan","family":"Ghobadi","sequence":"additional","affiliation":[{"name":"Mary Institute and Saint Louis Country Day School","place":["St. Louis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Ghobadi","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, Center for Gene and Cellular Immunotherapy (CGCI)","place":["St Louis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2019.01.005"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.002"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0098"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-419283"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009221"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.247"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-151185"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129319"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01869"},{"issue":"8","key":"e_1_3_4_20_1","first-page":"4572","article-title":"Nk cell responsiveness is tuned commensurate with the number of inhibitory receptors for self MHC class I: the rheostat model","volume":"182","author":"Joncker NT","year":"2009","unstructured":"Joncker NT, Fernandez NC, Treiner E, et al. Nk cell responsiveness is tuned commensurate with the number of inhibitory receptors for self MHC class I: the rheostat model. J Immunol Baltim Md 1950. 2009;182(8):4572\u20134580.","journal-title":"J Immunol Baltim Md 1950"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100570"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80300-3"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.03.006"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01207-0"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00491-0"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/35642"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1509173"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400330"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni929"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0556"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0732-7"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4797"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02462-0"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2341"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154334"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2981"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.226"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910607"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030264"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.12.012"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2022.07.001"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011532"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006619"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01983-z"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834002"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.07.008"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.10.011"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.10.002"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06384-w"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102975"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00364-6"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00808-3"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14374"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2023.03.018"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03153-9"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.02.005"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-019-00665-x"},{"issue":"4","key":"e_1_3_4_58_1","first-page":"652","article-title":"Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong JH","year":"1994","unstructured":"Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994;8(4):652\u2013658.","journal-title":"Leukemia"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000450"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2055-2"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00431-0"},{"issue":"6","key":"e_1_3_4_62_1","first-page":"1083","article-title":"First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia","volume":"8","author":"Tang X","year":"2018","unstructured":"Tang X, Yang L, Li Z, et al. First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. Am J Cancer Res. 2018;8(6):1083\u20131089.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1226518"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021015184"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz5618"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000621"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.06.002"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01455-z"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14993"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17186"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1384039"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361194"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108587"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010117"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01659-y"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00909"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac028"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023370"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13384"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03013"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0052-1"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129338"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01205"},{"key":"e_1_3_4_84_1","unstructured":"Zhang X. Anti-CD19 CAR NK cell therapy for relapsed or refractory B cell non-Hodgkin lymphoma: a multi-center uncontrolled trial. Report no.: NCT04639739. Available from clinicaltrials.gov; 2020 [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04639739"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100870"},{"key":"e_1_3_4_86_1","unstructured":"Hebei Yanda Ludaopei Hospital Sanhe Hebei China. Anti-CD19 CAR-engineered NK cells in the treatment of relapsed\/refractory acute lymphoblastic leukemia. Report no.: NCT05563545. ClinicalTrials.gov. 2025 [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05563545"},{"key":"e_1_3_4_87_1","unstructured":"Second Affiliated Hospital School of Medicine Zhejiang University. Clinical study of HLA haploidentical CAR-NK cells targeting CD19 in the treatment of refractory\/relapsed B-cell NHL. Report no.: NCT04887012. Available from clinicaltrials.gov; 2021 [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04887012"},{"key":"e_1_3_4_88_1","unstructured":"The Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu China. Safety and efficacy of allogenic CD19-CAR-NK cells in treatmenting r\/r B-cell hematologic malignancies. Report no.: NCT05739227. ClinicalTrials.gov. 2025 [cited 2025 Feb 16]. Available form: https:\/\/clinicaltrials.gov\/study\/NCT05739227"},{"key":"e_1_3_4_89_1","unstructured":"Second Affiliated Hospital School of Medicine Zhejiang University. Sequential treatment with 7x19 CAR-T after umbilical cord blood derived CD19 CARNK in relapsed\/refractory B cell lymphoma. Report no.: NCT06464861. Available from clinicaltrials.gov; 2025 [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06464861"},{"key":"e_1_3_4_90_1","unstructured":"2nd Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang China. Cord blood-derived CAR-NK cells targeting CD19 for refractory\/relapsed central nervous system lymphoma. Report no.: NCT06827782. ClinicalTrials.gov. 2025 [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06827782"},{"key":"e_1_3_4_91_1","unstructured":"Shenzhen Pregene Biopharma Co. Ltd. Clinical study of the safety and efficacy of chimeric antigen receptor NK cell injection targeting BCMA (BCMA CAR-NK) in patients with relapsed\/refractory multiple myeloma. Report no.: NCT05652530. Available from clinicaltrials.gov; 2022 [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05652530"},{"key":"e_1_3_4_92_1","unstructured":"Shanghai Changzheng Hospital Shanghai Shanghai Municipality China. To evaluate the safety and efficacy of human BCMA targeted CAR-NK cells injection for subjects with R\/R MM or PCL. Report no.: NCT06045091. ClinicalTrials.gov. 2025 [cited 2025 Feb 16]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06045091"},{"key":"e_1_3_4_93_1","unstructured":"The Children\u2019s Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang China. Anti-CD19\/BCMA CAR-NK cells in patients with B cell mediated autoimmune disease. Report no.: NCT06792799. ClinicalTrials.gov; [cited 2025 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06792799"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109041"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01083-5"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-021-10246-3"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00998-9"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953849"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.12.057"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-533398"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-015-0391-8"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.04.006"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1866287"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1407567"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3684-7_28"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2710"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1750743X.2025.2582464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:10Z","timestamp":1762866130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1750743X.2025.2582464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":105,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,10,13]]}},"alternative-id":["10.1080\/1750743X.2025.2582464"],"URL":"https:\/\/doi.org\/10.1080\/1750743x.2025.2582464","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}